American International Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-35,294
| Closed | -$1.49M | – | 2957 |
|
|
2024
Q1 | $1.49M | Buy |
35,294
+546
| +2% | +$23.1K | 0.01% | 1105 |
|
|
2023
Q4 | $1.47M | Buy |
34,748
+3,865
| +13% | +$164K | 0.01% | 1121 |
|
|
2023
Q3 | $674K | Buy |
30,883
+1,098
| +4% | +$24K | ﹤0.01% | 1441 |
|
|
2023
Q2 | $947K | Buy |
29,785
+2,136
| +8% | +$67.9K | 0.01% | 1276 |
|
|
2023
Q1 | $674K | Buy |
27,649
+550
| +2% | +$13.4K | ﹤0.01% | 1435 |
|
|
2022
Q4 | $855K | Buy |
27,099
+1,299
| +5% | +$41K | 0.01% | 1282 |
|
|
2022
Q3 | $729K | Buy |
25,800
+365
| +1% | +$10.3K | 0.01% | 1361 |
|
|
2022
Q2 | $673K | Buy |
25,435
+5,209
| +26% | +$138K | ﹤0.01% | 1423 |
|
|
2022
Q1 | $708K | Sell |
20,226
-1,423
| -7% | -$49.8K | ﹤0.01% | 1525 |
|
|
2021
Q4 | $702K | Sell |
21,649
-290
| -1% | -$9.4K | ﹤0.01% | 1619 |
|
|
2021
Q3 | $647K | Buy |
21,939
+2,180
| +11% | +$64.3K | ﹤0.01% | 1688 |
|
|
2021
Q2 | $506 | Buy |
+19,759
| New | +$506 | ﹤0.01% | 1912 |
|